SCHEMBL13613629

SCHEMBL13613629

O=C(NCc1ccc(Cl)cc1)Nc1cccc2c1CC(O)CC2

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 13/20 0.53
CLK4 Q9HAZ1 1/20 0.47
OPRM1 P35372 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
EPHX1 P07099 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2733680 0.90 TRPV1 (0.51) TRPV1CLK4OPRM1MEN1KMT2A
SCHEMBL13613606 0.90 TRPV1 (0.59) TRPV1OPRM1
SCHEMBL13613635 0.89 TRPV1 (0.54) TRPV1OPRM1
SCHEMBL4344935 0.89 TRPV1 (0.52) TRPV1MEN1KMT2AALDH1A1MAPT
SCHEMBL13613685 0.89 TRPV1 (0.52) TRPV1MEN1KMT2AALDH1A1MAPT
SCHEMBL13613682 0.89 TRPV1 (0.52) TRPV1MEN1KMT2AALDH1A1MAPT
SCHEMBL2734515 0.89 TRPV1 (0.50) TRPV1OPRM1EPHX1
SCHEMBL13613609 0.89 TRPV1 (0.51) TRPV1OPRM1MEN1KMT2AALDH1A1
SCHEMBL13613612 0.89 TRPV1 (0.55) TRPV1OPRM1MEN1KMT2AALDH1A1
SCHEMBL13613650 0.89 TRPV1 (0.51) TRPV1OPRM1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed